electroCore, Inc. (ECOR) Research

electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.

Market snapshot

Symbol
ECOR
Price
$8.43
Day change
-3.11%
Market cap
$69.9M
P/E ratio
-4.90x
52-week range
4.16-10.495
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 2 months

Peer companies

  • BioXcel Therapeutics, Inc. (BTAI)
  • Hyperion DeFi, Inc. (HYPD)
  • MAIA Biotechnology, Inc. (MAIA)
  • Myomo, Inc. (MYO)
  • NeuroOne Medical Technologies Corporation (NMTC)
  • PolyPid Ltd. (PYPD)
  • Vicarious Surgical Inc. (RBOT)
  • RenovoRx, Inc. (RNXT)

Recent insider activity

  • Lev Joshua S. — S-Sale (6667 shares) on 2026-05-28
  • Errico Thomas J. — P-Purchase (9992 shares) on 2026-05-21
  • Errico Thomas J. — L-Small (8 shares) on 2026-05-20
  • Lev Joshua S. — S-Sale (3000 shares) on 2026-05-22
  • Fox Michael — A-Award (70000 shares) on 2026-04-13

Open electroCore, Inc. (ECOR) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.